Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New series of 5-ht1F agonists disclosed by Lilly

Dec. 23, 1998

Cambridge NeuroScience and Bayer to collaborate on GGF2 development

Dec. 23, 1998

New market launch for novel anticonvulsant: Topamax available in Germany

Dec. 22, 1998

SmithKline Beecham patents combined 5-HT1A/5-HT1B/5-HT1D receptor antagonists

Dec. 22, 1998

Expanded indications, new formulation of Lamictal now available in U.S.

Dec. 21, 1998

First evidence that citicoline favorably affects human brain lipid metabolism

Dec. 21, 1998

EP1 receptor antagonists described by Ono for pain, fever and diuresis

Dec. 21, 1998

Allelix treatment for dementia enters phase I trials

Dec. 21, 1998

FDA approves Treatment IND for Orphan Medical's Xyrem oral solution

Dec. 21, 1998

U.K. launch for novel antipsychotic agent: zotepine

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...